April 17, 2011 – FDA Approves Actemra (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA).
Apr 2011 – FDA Approves Actemra
Announcement Date: April 17, 2011
April 17, 2011 – FDA Approves Actemra (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA).